Goodwin Procter LLP advised Q32 Bio on the deal. Q32 Bio announced its $60 million Series B financing co-led by OrbiMed Advisors and Acorn Bioventures. Q32…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now